Steward Financial Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$16K Hold
66
0.01% 278
2023
Q2
$18K Sell
66
-3
-4% -$893 0.01% 254
2023
Q1
$19K Buy
69
+38
+123% +$10.5K 0.01% 139
2022
Q4
$8K Buy
+31
New +$8.76K ﹤0.01% 162
2022
Q3
Sell
-37
Closed -$7K 215
2022
Q2
$7K Buy
+37
New +$7.56K 0.01% 285

Other funds holding BIIB

Steward Financial Group's BIIB Position: Q3 2023 in Review

Steward Financial Group held its Biogen (BIIB) position steady in Q3 2023 at 66 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #278.

Steward Financial Group first reported a position in BIIB in Q2 2022 and has held it in 5 quarters since. The position peaked at $19K in Q1 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Steward Financial Group held 66 shares of Biogen worth $16K as of Q3 2023.
  • Steward Financial Group left its Biogen share count unchanged in Q3 2023.
  • Biogen made up 0.01% of Steward Financial Group's portfolio in Q3 2023, its #278 holding.
  • Steward Financial Group first reported a position in Biogen in Q2 2022 and has held it in 5 quarters since.
  • Steward Financial Group's Biogen position peaked at $19K in Q1 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.